According to this model, a spatially confined suppressive TME develops in melanoma which is sustained by cytokine gradients upregulating MHC-II and IDO1 expression and by PD-1/PD-L1-mediated cell interactions (Nirmal et al., 2022). This evidence concerns the gene PDCD1 and melanoma.